Therefore, the aim of the present study was to investigate the correlation between the levels of CD1d on monocytes and the cytotoxicity of CD3+CD56+ T lymphocytes in AML and ALL patients. The gene discussed is NCAM1; the disease is acute myeloid leukemia.